MicroRNAs are implicated in the suppression of CD4+CD25- conventional T cell proliferation by CD4+CD25+ regulatory T cells

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 464-472

  Zhou, Sha ^a   Dong, Xiaoxiao ^a,b   Zhang, Cui ^a   Chen, Xiaojun ^a   Zhu, Jifeng ^a   Li, Wei ^a   Song, Xian ^a   Xu, Zhipeng ^a   Zhang, Weiwei ^a   Yang, Xiaowei ^a   Li, Yong ^a   Liu, Feng ^a   Su, Chuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Center for Disease Control and Prevention   (China)

Author keywords

Conventional T cell; MicroRNA; Proliferation; Regulatory T cell; Suppression

Indexed keywords

INTERLEUKIN 2; MICRORNA; MICRORNA 106B; MICRORNA 146A; MICRORNA 21; UNCLASSIFIED DRUG; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; IMMUNOREGULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

ANIMALS; ANTIGENS, CD4; CELL PROLIFERATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION PROFILING; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE, INBRED C57BL; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; T-LYMPHOCYTES, REGULATORY;

EID: 84912016825     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.10.001     Document Type: Article

References (28)

1. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., Garcia-Flores Y., Luong M., Devrekanli A., Xu J., Sun G., Tay J., Linsley P.S., Baltimore D. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 2011, 208:1189-1201.
2. Chu Y.W., Wang R., Schmid I., Sakamoto K.M. Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 1999, 36:333-339.
3. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V., Franceschini D., Meloni F., Barnaba V., Macino G. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
4. Das S., Ariizumi K., Cruz P.D. T-cell inhibitors: a bench-to-bedside review. Dermatitis: Contact Atopic Occup. Drug 2012, 23:195-202.
5. de la Rosa M., Rutz S., Dorninger H., Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 2004, 34:2480-2488.
6. Hu B., Bao G., Zhang Y., Lin D., Wu Y., Wu D., Liu H. Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation. J. Immunol. 2012, 189:1661-1670.
7. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28:2167-2174.
8. Kong K.L., Kwong D.L., Chan T.H., Law S.Y., Chen L., Li Y., Qin Y.R., Guan X.Y. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012, 61:33-42.
9. Li M.O., Sanjabi S., Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471.
10. Li Y., Dalli J., Chiang N., Baron R.M., Quintana C., Serhan C.N. Plasticity of leukocytic exudates in resolving acute inflammation is regulated by microRNA and proresolving mediators. Immunity 2013, 39:885-898.
11. Lindsay M.A. microRNAs and the immune response. Trends Immunol. 2008, 29:343-351.
12. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
13. Malek T.R. The biology of interleukin-2. Annu. Rev. Immunol. 2008, 26:453-479.
14. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 2007, 13:108-116.
15. Ng R., Song G., Roll G.R., Frandsen N.M., Willenbring H. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J. Clin. Invest. 2012, 122:1097-1108.
16. Palomares O., Yaman G., Azkur A.K., Akkoc T., Akdis M., Akdis C.A. Role of Treg in immune regulation of allergic diseases. Eur. J. Immunol. 2010, 40:1232-1240.
17. Popmihajlov Z., Xu D., Morgan H., Milligan Z., Smith K.A. Conditional IL-2 gene deletion: consequences for T cell proliferation. Front. Immunol. 2012, 3:102.
18. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
19. Sakaguchi S., Powrie F. Emerging challenges in regulatory T cell function and biology. Science 2007, 317:627-629.
20. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
21. Sander B., Hoiden I., Andersson U., Moller E., Abrams J.S. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J. Immunol. Methods 1993, 166:201-214.
22. Scheffold A., Huhn J., Hofer T. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. Eur. J. Immunol. 2005, 35:1336-1341.
23. Schmidt A., Oberle N., Krammer P.H. Molecular mechanisms of treg-mediated T cell suppression. Front. Immunol. 2012, 3:51.
24. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
25. Surh C.D., Sprent J. TGF-β puts the brakes on homeostatic proliferation. Nat. Immunol. 2012, 13:628-630.
26. Tsitsiou E., Lindsay M.A. microRNAs and the immune response. Curr. Opin. Pharmacol. 2009, 9:514-520.
27. Wang H., Liu J., Zong Y., Xu Y., Deng W., Zhu H., Liu Y., Ma C., Huang L., Zhang L., Qin C. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res. 2010, 1357:166-174.
28. Yu Y., Kanwar S.S., Patel B.B., Oh P.S., Nautiyal J., Sarkar F.H., Majumdar A.P. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 2012, 33:68-76.